Share Price:

APNASPENAspen Pharmacare Hldgs9485128 (1.37%)

Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award

Stephen Saad was presented with the prestigious Lifetime Achievement Award as well as the African of the Year Award at the 13th All Africa Business Leader Awards on 12 November 2025

Aspen highlights the rising diabetes disease burden

Aspen marked World Diabetes Day by highlighting the alarming economic, social, productivity and reduced life expectancy impact that diabetes is having on South Africa

Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified

Stephen Saad, Aspen Group Chief Executive

Aspen Pharmacare Holdings has reported financial results for the year ended 30 June 2025, with strong momentum in Commercial Pharmaceuticals and a modified Manufacturing strategy.

Aspen celebrates 15 years of commitment to Nelson Mandela Day

Stephen Saad, Aspen Group Chief Executive

The true heroes of our Mandela Day campaign are our employees who continue to volunteer to make a difference through their acts of selfless generosity, humility and care for those in need.

Aspen delivers strong results and advances its strategic ambitions

Stephen Saad Aspen Group Chief Executiv

Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.

Aspen announces local availability of Lilly’s Mounjaro

Stephen Saad, Aspen Group Chief Executive

Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro®, a therapeutic option available to physicians for the treatment of Type II diabetes.

Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day

Heinz Schütte, Aspen Pharmacare Regional CEO, Dr Reyna Daya, SEMDSA President & Endocrinologist, and Stavros Nicolau, Aspen Group Senior Executive Strategic Trade

Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly diabetes, in recognition of World Diabetes Day.

Aspen to participate in the Investec CEO conference in London

Stephen Saad, Aspen Group Chief Executive and Sean Capazorio, Aspen Group Chief Financial Officer

Aspen’s Stephen Saad and Sean Capazorio will take part in Investec’s CEO conference in London from 14 to 15 November 2024.

Aspen partners with PinkDrive to mobilise cancer screening

Aspen has contributed towards the funding of a new mobile cancer screening clinic for rural and peri-urban disadvantaged communities.

Aspen’s revenue increases 10% underpinned by a strong second half performance

Stephen Saad Aspen Group Chief Executiv

JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has reported solid Group financial results for the year ended 30 June 2024.

Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years

Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, is celebrating its 14th consecutive year of Group-wide participation in Mandela Day.   Stephen Saad, Aspen Group Chief Executive said, “ Aspen has a track record of improving access to healthcare to all patients but more particularly the… Continue reading Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years

Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships

Donald Ramphadi and Stavros Nicolaou at the handover of his high performance wheelchair

Johannesburg, South Africa – Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, has presented a state-of-the-art high performance wheelchair to South African wheelchair tennis star Donald Ramphadi.   Ramphadi, a French-open double quads champion and a prominent figure in wheelchair tennis, reached his maiden Grand Slam final at the Australian Open Wheelchair… Continue reading Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: